Literature DB >> 20507214

PAK1 as a therapeutic target.

Julia V Kichina1, Anna Goc, Belal Al-Husein, Payaningal R Somanath, Eugene S Kandel.   

Abstract

IMPORTANCE OF THE FIELD: P21-activated kinases (PAKs) are involved in multiple signal transduction pathways in mammalian cells. PAKs, and PAK1 in particular, play a role in such disorders as cancer, mental retardation and allergy. Cell motility, survival and proliferation, the organization and function of cytoskeleton and extracellular matrix, transcription and translation are among the processes affected by PAK1. AREAS COVERED IN THIS REVIEW: We discuss the mechanisms that control PAK1 activity, its involvement in physiological and pathophysiological processes, the benefits and the drawbacks of the current tools to regulate PAK1 activity, the evidence that suggests PAK1 as a therapeutic target and the likely directions of future research. WHAT THE READER WILL GAIN: The reader will gain a better knowledge and understanding of the areas described above. TAKE HOME MESSAGE: PAK1 is a promising therapeutic target in cancer and allergen-induced disorders. Its suitability as a target in vascular, neurological and infectious diseases remains ambiguous. Further advancement of this field requires progress on such issues as the development of specific and clinically acceptable inhibitors, the choice between targeting one or multiple PAK isoforms, elucidation of the individual roles of PAK1 targets and the mechanisms that may circumvent inhibition of PAK1.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20507214      PMCID: PMC3137287          DOI: 10.1517/14728222.2010.492779

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN: 1472-8222            Impact factor:   6.902


  232 in total

Review 1.  p21-activated kinases in cancer.

Authors:  Rakesh Kumar; Anupama E Gururaj; Christopher J Barnes
Journal:  Nat Rev Cancer       Date:  2006-06       Impact factor: 60.716

2.  Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease.

Authors:  Lixia Zhao; Qiu-Lan Ma; Frédéric Calon; Marni E Harris-White; Fusheng Yang; Giselle P Lim; Takashi Morihara; Oliver J Ubeda; Surendra Ambegaokar; James E Hansen; Richard H Weisbart; Bruce Teter; Sally A Frautschy; Greg M Cole
Journal:  Nat Neurosci       Date:  2006-01-15       Impact factor: 24.884

3.  CRIPak, a novel endogenous Pak1 inhibitor.

Authors:  A H Talukder; Q Meng; R Kumar
Journal:  Oncogene       Date:  2006-03-02       Impact factor: 9.867

4.  PAK1 hyperactivation is sufficient for mammary gland tumor formation.

Authors:  R-A Wang; H Zhang; S Balasenthil; D Medina; R Kumar
Journal:  Oncogene       Date:  2006-05-11       Impact factor: 9.867

5.  The GIT-associated kinase PAK targets to the centrosome and regulates Aurora-A.

Authors:  Zhuo-Shen Zhao; Jet Phey Lim; Yuen-Wai Ng; Louis Lim; Ed Manser
Journal:  Mol Cell       Date:  2005-10-28       Impact factor: 17.970

6.  Association between Pak1 expression and subcellular localization and tamoxifen resistance in breast cancer patients.

Authors:  Caroline Holm; Suresh Rayala; Karin Jirström; Olle Stål; Rakesh Kumar; Göran Landberg
Journal:  J Natl Cancer Inst       Date:  2006-05-17       Impact factor: 13.506

7.  Role of group A p21-activated kinases in activation of extracellular-regulated kinase by growth factors.

Authors:  Alexander Beeser; Zahara M Jaffer; Clemens Hofmann; Jonathan Chernoff
Journal:  J Biol Chem       Date:  2005-08-29       Impact factor: 5.157

8.  Active p21-activated kinase 1 rescues MCF10A breast epithelial cells from undergoing anoikis.

Authors:  Raymond E Menard; Andrew P Jovanovski; Raymond R Mattingly
Journal:  Neoplasia       Date:  2005-07       Impact factor: 5.715

Review 9.  RNA interference in cancer.

Authors:  Andrei L Gartel; Eugene S Kandel
Journal:  Biomol Eng       Date:  2006-02-08

10.  Essential role of CIB1 in regulating PAK1 activation and cell migration.

Authors:  Tina M Leisner; Mingjuan Liu; Zahara M Jaffer; Jonathan Chernoff; Leslie V Parise
Journal:  J Cell Biol       Date:  2005-08-01       Impact factor: 10.539

View more
  56 in total

1.  Pak1, adjuvant tamoxifen therapy, and breast cancer recurrence risk in a Danish population-based study.

Authors:  Thomas P Ahern; Deirdre P Cronin-Fenton; Timothy L Lash; Henrik Toft Sørensen; Anne Gulbech Ording; Stephen J Hamilton-Dutoit; Ylva Hellberg
Journal:  Acta Oncol       Date:  2016-04-08       Impact factor: 4.089

2.  p70 S6-kinase mediates the cooperation between Akt1 and Mek1 pathways in fibroblast-mediated extracellular matrix remodeling.

Authors:  Anna Goc; Harika Sabbineni; Maha Abdalla; Payaningal R Somanath
Journal:  Biochim Biophys Acta       Date:  2015-04-02

3.  P21-activated kinase 1 regulates resistance to BRAF inhibition in human cancer cells.

Authors:  Mahamat Babagana; Sydney Johnson; Hannah Slabodkin; Wiam Bshara; Carl Morrison; Eugene S Kandel
Journal:  Mol Carcinog       Date:  2017-02-23       Impact factor: 4.784

4.  Characterization of EHop-016, novel small molecule inhibitor of Rac GTPase.

Authors:  Brenda L Montalvo-Ortiz; Linette Castillo-Pichardo; Eliud Hernández; Tessa Humphries-Bickley; Alina De la Mota-Peynado; Luis A Cubano; Cornelis P Vlaar; Suranganie Dharmawardhane
Journal:  J Biol Chem       Date:  2012-03-01       Impact factor: 5.157

5.  Interrogation of kinase genetic interactions provides a global view of PAK1-mediated signal transduction pathways.

Authors:  Jae-Hong Kim; Yeojin Seo; Myungjin Jo; Hyejin Jeon; Young-Seop Kim; Eun-Jung Kim; Donggun Seo; Won-Ha Lee; Sang Ryong Kim; Nozomu Yachie; Quan Zhong; Marc Vidal; Frederick P Roth; Kyoungho Suk
Journal:  J Biol Chem       Date:  2020-10-15       Impact factor: 5.157

Review 6.  P21-activated kinase in inflammatory and cardiovascular disease.

Authors:  Domenico M Taglieri; Masuko Ushio-Fukai; Michelle M Monasky
Journal:  Cell Signal       Date:  2014-05-02       Impact factor: 4.315

7.  PAK1: A Therapeutic Target for Cancer Treatment.

Authors:  Ahmed F Abdel-Magid
Journal:  ACS Med Chem Lett       Date:  2013-03-19       Impact factor: 4.345

8.  Three-dimensional structural analysis reveals a Cdk5-mediated kinase cascade regulating hepatic biliary network branching in zebrafish.

Authors:  Manali Dimri; Cassandra Bilogan; Lain X Pierce; Gregory Naegele; Amit Vasanji; Isabel Gibson; Allyson McClendon; Kevin Tae; Takuya F Sakaguchi
Journal:  Development       Date:  2017-07-15       Impact factor: 6.868

9.  PAK1 inhibitor IPA-3 mitigates metastatic prostate cancer-induced bone remodeling.

Authors:  Arti Verma; Sandeep Artham; Abdulrahman Alwhaibi; Mir S Adil; Brian S Cummings; Payaningal R Somanath
Journal:  Biochem Pharmacol       Date:  2020-03-30       Impact factor: 5.858

10.  P21 activated kinase-1 (Pak1) promotes prostate tumor growth and microinvasion via inhibition of transforming growth factor β expression and enhanced matrix metalloproteinase 9 secretion.

Authors:  Anna Goc; Ahmad Al-Azayzih; Maha Abdalla; Belal Al-Husein; Sravankumar Kavuri; Jeffrey Lee; Kelvin Moses; Payaningal R Somanath
Journal:  J Biol Chem       Date:  2012-12-20       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.